Will Synthetically Engineered Immune Cells Stop AIDS?

Armen Hareyan's picture
Advertisement

Twenty years after its introduction, gene therapy still holds great promise as a way to harness the insidious power of viruses such as human immunodeficiency syndrome (HIV). But scientists have yet to solve a vexing problem: developing an efficient transport system that is capable of delivering therapeutic payloads to specific cells.

As challenging as the problem has been, researchers in the Viterbi School of Engineering may be turning a corner.

Advertisement